Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up study of weekly Paclical treatment in metastatic breast cancer (OAS-11PAC-W extension)
2011-002456-14Phase 2Terminated
- Sponsor
- Vivesto AB
- Start
- Aug 2011
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel micellar in breast cancer, sponsored by Vivesto AB. Primary endpoint: Time in study (number of treatment cycles) related to reason for completion. Started Aug 2011; status: terminated.
02
Drugs
paclitaxel micellar
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-002456-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002456-14.